Impact of optimal medical therapy with SGLT2 inhibitor on left ventricular ejection fraction recovery in a pre vs post guideline era in HFrEF patients fitted with a wearable cardioverter defibrillator
EVOLUTION HF - Early treatment of heart failure: a non-interventional study program of patients with heart failure and initiated on dapagliflozin: study design of German EVOLUTION HF DEallEF study
Assessment of PVR and other hemodynamic parameters in HFpEF and HFmrEF patients with new-onset SGLT-2 inhibitor: Comparison of PAP sensor-derived and echo-based approaches